Pedersen et al., 1990 - Google Patents
Feline leukemia virus infection as a potentiating cofactor for the primary and secondary stages of experimentally induced feline immunodeficiency virus infectionPedersen et al., 1990
View PDF- Document ID
- 16621653251060335801
- Author
- Pedersen N
- Torten M
- Rideout B
- Sparger E
- Tonachini T
- Luciw P
- Ackley C
- Levy N
- Yamamoto J
- Publication year
- Publication venue
- Journal of virology
External Links
Snippet
Preexistent feline leukemia virus (FeLV) infection greatly potentiated the severity of the transient primary and chronic secondary stages of feline immunodeficiency virus (FIV) infection. Of 10 FeLV-FIV carrier cats, 5 died of experimentally induced FIV infection …
- 241000713800 Feline immunodeficiency virus 0 title abstract description 160
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriphage
- C12Q1/701—Specific hybridization probes
- C12Q1/702—Specific hybridization probes for retroviruses
- C12Q1/703—Viruses associated with AIDS
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse Transcribing RNA Viruses
- C12N2740/00011—Reverse Transcribing RNA Viruses
- C12N2740/10011—Retroviridae
- C12N2740/14011—Deltaretrovirus, e.g. bovine leukeamia virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse Transcribing RNA Viruses
- C12N2740/00011—Reverse Transcribing RNA Viruses
- C12N2740/10011—Retroviridae
- C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Pedersen et al. | Feline leukemia virus infection as a potentiating cofactor for the primary and secondary stages of experimentally induced feline immunodeficiency virus infection | |
| Haase | Pathogenesis of lentivirus infections | |
| Gessain et al. | Low degree of human T-cell leukemia/lymphoma virus type I genetic drift in vivo as a means of monitoring viral transmission and movement of ancient human populations | |
| Alvar et al. | Leishmania and human immunodeficiency virus coinfection: the first 10 years | |
| Dandekar et al. | Detection of feline immunodeficiency virus (FIV) nucleic acids in FIV-seronegative cats | |
| DeFreitas et al. | Retroviral sequences related to human T-lymphotropic virus type II in patients with chronic fatigue immune dysfunction syndrome. | |
| Biberfeld et al. | HTLV-III expression in infected lymph nodes and relevance to pathogenesis of lymphadenopathy. | |
| Fultz et al. | Persistent infection of chimpanzees with human T-lymphotropic virus type III/lymphadenopathy-associated virus: a potential model for acquired immunodeficiency syndrome | |
| Hirsch et al. | Simian immunodeficiency virus infection of macaques: end-stage disease is characterized by widespread distribution of proviral DNA in tissues | |
| Spear et al. | Neutralization of human immunodeficiency virus type 1 by complement occurs by viral lysis | |
| Vandamme et al. | Use of a generic polymerase chain reaction assay detecting human T‐lymphotropic virus (HTLV) types I, II and divergent simian strains in the evaluation of individuals with indeterminate HTLV serology | |
| Matteucci et al. | Detection of feline immunodeficiency virus in saliva and plasma by cultivation and polymerase chain reaction | |
| Melief et al. | Transmission of lymphotropic retroviruses (HTLV-I and LAV/HTLV-III) by blood transfusion and blood products | |
| Lin et al. | Immunological changes in cats with concurrent Toxoplasma gondii and feline immunodeficiency virus infections | |
| US4900548A (en) | Use of diethylcarbamazine to enhance antigen-antibody and antigen-host immune cell interactions | |
| Bishop et al. | Vaginal and rectal infection of cats with feline immunodeficiency virus | |
| Kishi et al. | Cells surviving infection by human immunodeficiency virus type 1: vif or vpu mutants produce non-infectious or markedly less cytopathic viruses | |
| Vahlenkamp et al. | (R)-9-(2-phosphonylmethoxypropyl)-2, 6-diaminopurine is a potent inhibitor of feline immunodeficiency virus infection | |
| Reubel et al. | Effect of chronic feline immunodeficiency virus infection on experimental feline calicivirus-induced disease | |
| Schüpbach | Human retrovirology | |
| Barr et al. | Isolation of a highly cytopathic lentivirus from a nondomestic cat | |
| Yoshimura et al. | Intrapatient sequence variation of the gag gene of human immunodeficiency virus type 1 plasma virions | |
| Barker et al. | CD8+ cells from asymptomatic human immunodeficiency virus-infected individuals suppress superinfection of their peripheral blood mononuclear cells | |
| Zenger et al. | Evaluation of cofactor effect of feline syncytium-forming virus on feline immunodeficiency virus infection | |
| Hoover et al. | Feline leukemia virus-induced immunodeficiency syndrome in cats as a model for evaluation of antiretroviral therapy |